Prevalence, Impact, and Risk Factors for Hospital-Acquired Conditions after Major Surgical Resection for Cancer: A NSQIP Analysis

Journal of Gastrointestinal Surgery

Volumn 19, Issue 1, 2015, Pages 142-151

  Molena, Daniela ^a   Mungo, Benedetto ^a   Stem, Miloslawa ^a   Feinberg, Richard L ^a   Lidor, Anne O ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Hospital acquired condition; Outcomes; Surgery

Indexed keywords

AGED; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NEOPLASMS; PREVALENCE; RISK FACTOR; SURGICAL WOUND INFECTION; SURVIVAL RATE; TRENDS; UNITED STATES; URINARY TRACT INFECTIONS; VENOUS THROMBOEMBOLISM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; RISK FACTORS; SURGICAL WOUND INFECTION; SURVIVAL RATE; UNITED STATES; URINARY TRACT INFECTIONS; VENOUS THROMBOEMBOLISM;

EID: 84920599529     PISSN: 1091255X     EISSN: 18734626     Source Type: Journal    
DOI: 10.1007/s11605-014-2642-x     Document Type: Article

References (20)

1. Kohn LT, Corrigan JM, Donaldson MS. To err is human: building a safer health system. Institute of Medicine (US) Committee on Quality of Health Care in America 2000, Washington, DC: National Academies Press
2. Mello et al. Who pays for medical errors? An analysis of adverse event costs, medial liability system and incentives for patient safety improvement. Journal of Empirical Legal Studies 2007;4–4: 835–860
3. Weeks WB, Wallace AE. Broadening the business case for patient safety. Arch Intern Med 2003;163:1112; author reply 1113
4. Centers for Medicare and Medicaid Services: Hospital-acquired conditions. Available at http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HospitalAcqCond/Hospital-Acquired_Conditions.html. Accessed on April 10, 2014
5. Lee GM, Kleinman K, Soumerai SB, Tse A, Cole D, Fridkin SK, Horan T, Platt R, Gay C, Kassler W, Goldmann DA, Jernigan J, Jha AK. Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med 2012;367:1428–1437.
6. Centers for Medicare and Medicaid Services: 2013 Final HAC list. Available at http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HospitalAcqCond/Downloads/FY_2013_Final_HACsCodeList.pdf. Accessed April 10, 2014.
7. Patel JD, Krilov L, Adams S, Aghajanian C, Basch E, Brose MS, Carroll WL, de Lima M, Gilbert MR, Kris MG, Marshall JL, Masters GA, O’Day SJ, Polite B, Schwartz GK, Sharma S, Thompson I, Vogelzang NJ, Roth BJ. Clinical Cancer Advances 2013: annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol 2014;32:129–160.
8. American College of Surgeons National Surgical Quality Improvement Program. Participants. Chicago, IL, USA. Available at: http://site.acsnsqip.org/participants. Accessed March 21, 2014.
9. American College of Surgeon National Surgical Quality Improvement Program. ACS-NSQIP user guide for the 2011 Participant Data Use File. http://site.acsnsqip.org/wp-content/uploads/2012/03/2011-User-Guide_Final.pdf. Accessed March 21, 2014
10. Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. The Lancet Oncology 2005;6:401–410.
11. Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, Riera-Knorrenschild J, Langer P, Engenhart-Cabillic R, Bitzer M, Konigsrainer A, Budach W, Wilke H. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 2009;27:851–856.
12. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ, Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638–646.
13. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A, CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012; 366:2074–2084.
14. Ismael H, Horst M, Farooq M, Jordon J, Patton JH, Rubinfeld IS. Adverse effects of preoperative steroid use on surgical outcomes. Am J Surg 2011;201:305–8; discussion 308–9.
15. Palesty JA, Dudrick SJ. Cachexia, malnutrition, the refeeding syndrome, and lessons from Goldilocks. Surg Clin North Am 2011;91:653–673.
16. Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med 2005;118:978–980.
17. Waisbren E, Rosen H, Bader AM, Lipsitz SR, Rogers SO,Jr, Eriksson E. Percent body fat and prediction of surgical site infection. J Am Coll Surg 2010;210:381–389.
18. Duska LR, Garrett L, Henretta M, Ferriss JS, Lee L, Horowitz N. When ‘never-events’ occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes. Gynecol Oncol 2010;116:374–377.
19. Chan JY, Semenov YR, Gourin CG. Postoperative urinary tract infection and short-term outcomes and costs in head and neck cancer surgery. Otolaryngol Head Neck Surg 2013;148:602–610.
20. Hall BL, Hamilton BH, Richards K, Bilimoria KY, Cohen ME, Ko CY. Does surgical quality improve in the American College of Surgeons National Surgical Quality Improvement Program: an evaluation of all participating hospitals. Ann Surg 2009;250:363–376